Drug
Opc 34712fum Brexpiprazole
Opc 34712fum Brexpiprazole: highest development phase Phase 3, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| OPC-34712FUM/ Brexpiprazole fumarate NCT05326347 | Phase 3 | Schizophrenia |
Latest
No recent events.
Follow Opc 34712fum Brexpiprazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.